Heart Defects, CongenitalTetralogy of FallotPulmonary Valve InsufficiencyPulmonary Valve Stenosis
Investigational drug(s) / intervention(s)
GORE PV1
GORE PV1: Implantation of GORE PV1 Device for procedure to replace the pulmonary valve and reconstruct the right ventricular outflow tract (RVOT).
Study summary
This study will assess the safety and performance of the GORE PV1 Device for replacement of the pulmonary valve and reconstruction of the Right Ventricular Outflow Tract (RVOT).
Eligibility
Sex
ALL
Min age
5 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. A symptomatic or appropriate asymptomatic subject with a native or repaired right ventricular outflow tract requiring reconstruction with a valved conduit
2. Age ≥5 years at the time of informed consent signature.
Note: Additional Inclusion Criteria may apply
Exclusion Criteria:
1. An artificial valve at another position or will need an artificial valve at another position (i.e. replacement at the time of index procedure or anticipated within 3 years).
2. Subjects with previously implanted pacemaker (including defibrillators).
3. Major or progressive non-cardiac disease (liver failure, renal failure, cancer) that has a life expectancy of less than one year.
Note: Additional Exclusion Criteria may apply
Primary outcome measure(s)
Valve-related mortality and device-related re-intervention — 6 months The composite of valve-related mortality and device-related re-intervention measured at 6 months post-procedure
Trial sites (3)
Facility
City
Region
Status
Lurie Children's Hospital
Chicago
Illinois
Boston Children's Hospital
Boston
Massachusetts
Nationwide Children's Hospital
Columbus
Ohio
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.